Found 6 resultsAuthor Title Type [ Year]
Filters: First Letter Of Title is C and Author is Fast, P [Clear All Filters]
Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers. In HIVR4P (HIV Research for Prevention). presented at the 28/10/2014, Cape Town, South Africa. Retrieved from http://hivr4p.org/. (2014).
Cellular and Humoral Immunogenicity of ADMVA, a Clade C/B MVA-Based HIV-1 Candidate Vaccine, in Healthy Volunteers. In AIDS Vaccine 2007 Conference. presented at the 20/08/2007, Seattle, WA. Retrieved from http://www.vaccineenterprise.org/conference_archive/2007/index.html. (2007).
Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience. In AIDS Vaccine 2007 Conference. presented at the 02/08/2007, Seattle, WA. Retrieved from http://www.vaccineenterprise.org/conference_archive/2007/index.html. (2007).
Challenges Experienced By the Clinical Team During The Conduct of HIV Vaccine Clinical Trials in Kenya. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.. (2005).
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. J Infect Dis, 180(2), 290-8. presented at the 1999 Aug. doi:10.1086/314895. (1999).